BUSINESS
J-TEC Prepping to File for Allogeneic Cultured Epidermis, Eyes Overseas Export
Japan Tissue Engineering (J-TEC) said on September 17 that it has completed its clinical trial for Allo-JaCE03, a dried cultured epidermis made from allogeneic skin cells. The company will begin preparations for its regulatory filing, aiming for its launch in…
To read the full story
Related Article
- J-TEC to Start Study of Allogeneic Cultured Epidermis for DDB Patients
November 26, 2021
BUSINESS
- Pfizer, ASKA to Co-Promote RSV Vaccine Abrysvo in Japan
March 9, 2026
- Sumitomo to Launch Post-Marketing Study for iPSC Therapy by Year-End
March 9, 2026
- Drug Pricing Reform Draws Sharp Industry Backlash in Jiho Poll
March 9, 2026
- Nitrosamine Detected in Nichi-Iko’s Tryptanol, No Need to Halt Prescriptions
March 9, 2026
- Towa Broadens Label for Tacrolimus in Cell Transplantation
March 9, 2026
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…





